Trial Profile
A trial to evaluate the efficacy and safety of paclitaxel (Genexol® -PM) monotherapy in patients with recurrent or metastatic breast cancer (MBC)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Jun 2016
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- 03 Jun 2016 New trial record